| Citation: | SHI Peng, WU Xinyu, HUAI Yushui, SONG Hongwei, NIAN Di. Significance and mechanism of neuroultrasound combined with neuromagnetic resonance imaging in the diagnosis and treatment of Guillain-Barré syndrome[J]. Chinese Journal of General Practice, 2025, 23(8): 1292-1297. doi: 10.16766/j.cnki.issn.1674-4152.004118 |
| [1] |
HE S, LIN Y. Application and value of limbs peripheral nerve ultrasound in Guillain-Barre syndrome[J]. Altern Ther Health M, 2024, 30(10): 416-421.
|
| [2] |
SHEN D, CHU F, LANG Y, et al. Nuclear factor Kappa B inhibitor suppresses experimental autoimmune neuritis in mice via declining macrophages polarization to M1 type[J]. Clin Exp Immunol, 2021, 206(1): 110-117. doi: 10.1111/cei.13637
|
| [3] |
DASH S, KAMATH U, PAI A R, et al. Serum inflammatory markers in patients with guillain barre syndrome[J]. Neurol India, 2022, 70(5): 2082-2085. doi: 10.4103/0028-3886.359238
|
| [4] |
VELTSISTA D, KEFALOPOULOU Z, KINTOS V, et al. Identical late motor responses in early Guillain-Barré syndrome: a-waves and repeater F-waves[J]. J Peripher Nerv Syst, 2023, 28(1): 41-46. doi: 10.1111/jns.12522
|
| [5] |
FOKKE C, VAN DEN BERG B, DRENTHEN J, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria[J]. Brain, 2014, 137(1): 33-43. doi: 10.1093/brain/awt285
|
| [6] |
RATH J, ZULEHNER G, SCHOBER B, et al. Cerebrospinal fluid analysis in Guillain-Barré syndrome: value of albumin quotients[J]. J Neurol, 2021, 268(9): 3294-3300. doi: 10.1007/s00415-021-10479-9
|
| [7] |
KMEZIC I, GUSTAFSSON R, HANSSON M, et al. Beta-trace protein in chronic inflammatory demyelinating polyradiculoneuropathy and Guillain-Barre syndrome-clinical utilization and a new insight into pathophysiological mechanisms[J]. J Neurol Sci, 2025, 15: 123439. DOI: 10.1016/j.jns.2025.123439.
|
| [8] |
BOURQUE PR, BREINER A, MOHER D, et al. Adult CSF total protein: higher upper reference limits should be considered worldwide. A web-based survey[J]. J Neurol Sci, 2019, 15(396): 48-51.
|
| [9] |
GOMEZ Á, DIAZ A, CARRION-PENAGOS J, et al. Clinical and electrophysiological characteristics of Guillain-Barré syndrome in Colombia[J]. Peripher Nerv Syst, 2019, 24(3): 268-271. doi: 10.1111/jns.12340
|
| [10] |
KENAN G, REGEV T, KUSHNIR M, et al. Reasons for delayed treatment initiation in Guillain-Barre syndrome[J]. J Neurol Sci, 2022, 434: 120179. DOI: 10.1016/j.jns.2022.120179.
|
| [11] |
GOYAL K, AGGARWAL P, GUPTA M. Ultrasound evaluation of peripheral nerves of the lower limb in diabetic peripheral neuropathy[J]. Eur J Radiol, 2021, 145: 110058. DOI: 10.1016/j.ejrad.2021.110058.
|
| [12] |
SEEJITH K, SASIDHARANPILLAI S, AJITHKUMAR K, et al. High resolution ultrasound in the assessment of peripheral nerves in leprosy: a comparative cross-sectional study[J]. Indian J Dermatol Ve, 2021, 87(2): 199-206.
|
| [13] |
崔凯丽, 黄培君, 苏庆杰. 抗CD20单克隆抗体联合FcRn拮抗剂治疗多种神经节苷脂抗体阳性的慢性吉兰-巴雷综合征1例[J]. 河北医学, 2025, 31(1): 174-176.
CUI K L, HUANG P J, SU Q J. One case of chronic Guillain-Barre syndrome positive for multiple ganglioside antibodies was treated with anti-CD20 monoclonal antibody combined with FcRn antagonist[J]. Hebei Medicine, 2025, 31(1): 174-176.
|
| [14] |
ALANAZY M H, BAKRY S S, ALQAHTANIl A, et al. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study[J]. BMC Neurol, 2021, 21(1): 275-283. doi: 10.1186/s12883-021-02314-5
|
| [15] |
LI X Y, YU M, ZHOU X L, et al. A method of ultrasound diagnosis for unilateral peripheral entrapment neuropathy based on multilevel side-to-side image contrast[J]. Math Biosci Eng, 2019, 16(4): 2250-2265. doi: 10.3934/mbe.2019111
|
| [16] |
GRIMM A, DECARD B F, SCHRAMM A, et al. Ultrasound and electrophysiologic findings in patients with Guillain-Barré syndrome at disease onset and over a period of six months[J]. Clin Neyrophysiol, 2016, 127(2): 1657-1663. doi: 10.1016/j.clinph.2015.06.032
|
| [17] |
ALTHUBAITIl F, GUIOMARD C, RIVIER F, et al. Prognostic value of contrast-enhanced MRI in Guillain-Barré syndrome in children[J]. Arch Pediatrie, 2022, 29 (3): 230-235. doi: 10.1016/j.arcped.2022.01.004
|
| [18] |
LI X, YANG L, WANG G, et al. Extensive cytokine biomarker analysis of Guillain-Barré Syndrome[J]. Sci Rep, 2023, 13(1): 8354-8366. doi: 10.1038/s41598-023-35610-w
|
| [19] |
漆星月, 赵旭东, 李雷. 炎症负荷指数与吉兰-巴雷综合征严重程度的相关性分析[J]. 中华全科医学, 2024, 22(9): 1487-1490. doi: 10.16766/j.cnki.issn.1674-4152.003665
QI X Y, ZHAO X D, LI L. Correlation analysis between the inflammatory burden index and the severity of Guillain-Barre syndrome[J]. Chinese Journal of General Practice, 2024, 22(9): 1487-1490. doi: 10.16766/j.cnki.issn.1674-4152.003665
|
| [20] |
HIGASHIKUNI Y, LIU W, NUMATA G, et al. NLRP3 infammasome activation through heart-brain interaction initiates cardiac infammation and hypertrophy during pressure overload[J]. Circulation, 2023, 147(4): 338-355. doi: 10.1161/CIRCULATIONAHA.122.060860
|
| [21] |
DE CARVALHO RIBEIRO M, IRACHETA-VALLVE A, BABUTA M, et al. Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation[J]. Hepatology, 2023, 78(1): 225-242. doi: 10.1097/HEP.0000000000000298
|
| [22] |
WU X, GONG L, XIE L, et al. NLRP3 defciency protects against intermittent hypoxia-induced neuroinfammation and mitochondrial ROS by promoting the PINK1-Parkin pathway of mitophagy in a murine model of sleep apnea[J]. Front Immunol, 2021, 12: 628168. DOI: 10.3389/fimmu.2021.628168.
|